6-acetyl-4-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo(b)pyran-3-ol,
SB 220453,
SB-220453,
tonabersat,
Tonabersat,
175013-84-0,
SB-220453,
SB 220453,
UNII-2XD9773ZMN,
2XD9773ZMN,
N-((3S,4S)-6-Acetyl-3-hydroxy-2,2-dimethylchroman-4-yl)-3-chloro-4-fluorobenzamide,
N-[(3S,4S)-6-Acetyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-3-chloro-4-fluoro-benzamide,
Tonabersat [INN:BAN],
USL-260,
AC1OCFAG,
C20H19ClFNO4,
6-acetyl-4-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo(b)pyran-3-ol,
CHEMBL318191,
SCHEMBL5917016,
Tonabersat, >=98% (HPLC),
DTXSID40169923,
XLIIRNOPGJTBJD-ROUUACIJSA-N,
N-[(3S,4S)-6-acetyl-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-3-chloro-4-fluorobenzamide,
ZINC3823813,
MFCD00944458,
AKOS015994581,
CS-0676,
ES-0039,
SB17501,
NCGC00379030-01,
AJ-45738,
HY-15204,
SB220453,
X6315,
W-5238,
SB-220453;SB 220453;SB220453,
(3S,4S)-6-Acetyl-4-(3-chloro-4-fluorobenzamido)-3,4-dihydro-2,2-dimethyl-3-hydroxy-2H-1-benzopyran,
(3S-cis)-N-(6-acetyl-3,4-dihydro-3-hydroxy-2,2 -(dimethyl-d6)-2H-1-benzopyran-4-yl)-3-chloro-4-fluorobenzamide,
(3S-cis)-N-(6-acetyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-3-chloro-4-fluorobenzamide,
2H-Benzo(b)pyran-3-ol, 6-acetyl-4-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-,
Benzamide, N-[(3S,4S)-6-acetyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-3-chloro-4-fluoro-,
N-[(3S,4S)-6-Acetyl-3-hydroxy-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-yl]-3-chloro-4-fluorobenzamide,
D0E8IZ,
5-HT1d agonist (migraine), SB,
5-HT1d agonist (migraine), Minster,
CID6918324,
A11593,
C118706,